Literature DB >> 28384595

Clinical outcomes from maximum-safe resection of primary and metastatic brain tumors using awake craniotomy.

Anastasia Groshev1, Devang Padalia2, Sephalie Patel2, Rosemarie Garcia-Getting2, Solmaz Sahebjam1, Peter A Forsyth1, Frank D Vrionis3, Arnold B Etame4.   

Abstract

OBJECTIVE: To retrospectively analyze outcomes in patients undergoing awake craniotomies for tumor resection at our institution in terms of extent of resection, functional preservation and length of hospital stay. PATIENTS AND METHODS: All cases of adults undergoing awake-craniotomy from September 2012-February 2015 were retrospectively reviewed based on an IRB approved protocol. Information regarding patient age, sex, cancer type, procedure type, location, hospital stay, extent of resection, and postoperative complications was extracted.
RESULTS: 76 patient charts were analyzed. Resected cancer types included metastasis to the brain (41%), glioblastoma (34%), WHO grade III anaplastic astrocytoma (18%), WHO grade II glioma (4%), WHO grade I glioma (1%), and meningioma (1%). Over a half of procedures were performed in the frontal lobes, followed by temporal, and occipital locations. The most common indication was for motor cortex and primary somatosensory area lesions followed by speech. Extent of resection was gross total for 59% patients, near-gross total for 34%, and subtotal for 7%. Average hospital stay for the cohort was 1.7days with 75% of patients staying at the hospital for only 24h or less post surgery. In the postoperative period, 67% of patients experienced improvement in neurological status, 21% of patients experienced no change, 7% experienced transient neurological deficits, which resolved within two months post op, 1% experienced transient speech deficit, and 3% experienced permanent weakness.
CONCLUSIONS: In a consecutive series of 76 patients undergoing maximum-safe resection for primary and metastatic brain tumors, awake-craniotomy was associated with a short hospital stay and low postoperative complications rate.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Awake craniotomy; Brain tumor; Glioma; Metastases; Outcomes; Resection

Mesh:

Year:  2017        PMID: 28384595     DOI: 10.1016/j.clineuro.2017.03.017

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  6 in total

1.  Glioma surgery under awake condition can lead to good independence and functional outcome excluding deep sensation and visuospatial cognition.

Authors:  Riho Nakajima; Masashi Kinoshita; Hirokazu Okita; Tetsutaro Yahata; Mitsutoshi Nakada
Journal:  Neurooncol Pract       Date:  2018-12-20

2.  Comparison of the Functional State and Motor Skills of Patients after Cerebral Hemisphere, Ventricular System, and Cerebellopontine Angle Tumor Surgery.

Authors:  Stanisław Krajewski; Jacek Furtak; Monika Zawadka-Kunikowska; Michał Kachelski; Marcin Birski; Marek Harat
Journal:  Int J Environ Res Public Health       Date:  2022-02-17       Impact factor: 3.390

3.  Longitudinal assessment of network reorganizations and language recovery in postoperative patients with glioma.

Authors:  Binke Yuan; Nan Zhang; Fangyuan Gong; Xindi Wang; Jing Yan; Junfeng Lu; Jinsong Wu
Journal:  Brain Commun       Date:  2022-04-06

4.  Indication and eligibility of glioma patients for awake surgery: A scoping review by a multidisciplinary perspective.

Authors:  Giorgio Fiore; Giorgia Abete-Fornara; Arianna Forgione; Leonardo Tariciotti; Mauro Pluderi; Stefano Borsa; Cristina Bana; Filippo Cogiamanian; Maurizio Vergari; Valeria Conte; Manuela Caroli; Marco Locatelli; Giulio Andrea Bertani
Journal:  Front Oncol       Date:  2022-09-21       Impact factor: 5.738

5.  Rehabilitation Outcomes for Patients with Motor Deficits after Initial and Repeat Brain Tumor Surgery.

Authors:  Stanisław Krajewski; Jacek Furtak; Monika Zawadka-Kunikowska; Michał Kachelski; Marcin Birski; Marek Harat
Journal:  Int J Environ Res Public Health       Date:  2022-08-31       Impact factor: 4.614

6.  Intra- and postoperative adverse events in awake craniotomy for intrinsic supratentorial brain tumors.

Authors:  Borys M Kwinta; Aneta M Myszka; Monika M Bigaj; Roger M Krzyżewski; Anna Starowicz-Filip
Journal:  Neurol Sci       Date:  2020-08-17       Impact factor: 3.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.